Lucintel's latest market report analyzed that prostate health provides attractive opportunities in pharmacies and e-commerce stores. The prostate health market is expected to reach $58.9 billion by 2028 with a CAGR of 9.1%. In this market, prostate cancer is the largest segment by disease indication, whereas e-commerce store is largest by disease indication.
Download Brochure of this report by clicking on https://www.lucintel.com/prostate-health-market.aspx.
Based on disease
indication, the prostate health market is segmented into prostate cancer,
prostatitis, alpha blockers, benign prostate hyperplasia, and others. The
prostate cancer segment accounted for the largest share of the market in 2023
and is expected to register the highest CAGR during the forecast period, due to
because augmenting cancer cases has influenced the usage of immunotherapies to
inhibit prostate cancer cells from spreading. Also, hormone therapy is
generally used to effectively treat cancer at the initial stage.
Browse in-depth TOC on “Prostate
Health Market”
100 – Figures/Tables
150 – Pages
The Prostate Health
Market is marked by the presence of several big and small players. Some of the
prominent players offering prostate health include Eli Lilly and Company,
Pfizer, Merck & Co., Abbott, Endo Pharmaceuticals, GlaxoSmithKline PLC,
Siemens Healthcare, Amgen, and AstraZeneca.
Request Sample Report:
https://www.lucintel.com/prostate-health-market.aspx
This unique research report will enable you
to make confident business decisions in this globally competitive marketplace. For
a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on
this link helpdesk@lucintel.com.
About Lucintel
Lucintel,
the premier global management consulting and market research firm, creates
winning strategies for growth. It offers market assessments, competitive
analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Roy Almaguer
Lucintel
Dallas,
Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related reports
Mhealth
Solution Market:
For more details click here https://www.lucintel.com/mhealth-solution-market.aspx
Minimally
Invasive Surgery Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgery-market.aspx
Medical Aesthetic Market:
For more details click here https://www.lucintel.com/medical-aesthetic-market.aspx
Neurostimulation Market:
For more details click here https://www.lucintel.com/neurostimulation-market.aspx
Nuclear Medicine/Radiopharmaceutical Market:
For more details click here https://www.lucintel.com/nuclear-medicine-radiopharmaceutical-market.aspx
Liquid Biopsy Market:
For more details click here https://www.lucintel.com/liquid-biopsy-market.aspx
Digital
Fitness Market:
For more details click here https://www.lucintel.com/digital-fitness-market.aspx
Digital X-Ray Market:
For more details click here https://www.lucintel.com/digital-xray-market.aspx
Medical
Robot Market:
For more details click here https://www.lucintel.com/medical-robot-market.aspx
Healthcare IT Market:
No comments:
Post a Comment